PRRT2 and Hyperglycemia: Hyperglycemia leads to microvascular and macrovascular complications in the diabetic patients through four major pathways–polyol pathway, activation of advanced glycation end products (AGEs), activation of hexosamine pathway and activation of protein kinase C (PKC).